Search
    
    
                
                
                
              
              
              Dabrafenib is mainly used for the treatment of unresectable or metastatic melanoma caused by a defect in the BRAF gene. Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.
Items  | Specification  | Result  | 
Assay  | ≥98%  | 98.59%  | 
Appearance  | White or slight colour solid  | Off white solid  | 
Loss on drying  | ≤0.5%  | 0.26%  | 
Welcome to inquiry us to get the complete COA of Dabrafenib!
| Product parameters | |
| Cas number: | 1195765-45-7 | 
| Appearance: | White to slight colour solid | 
| Purity: | 98%min | 
| Package details: | 1kg/bag with foil bag;25kg/drum | 
| Brand: | Fortunachem | 
Guaranteed the purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment


      Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
        
      Quick Links
Add:
E-mail:
English                  
Español                  
français                  
العربية